Skip to main content

We're increasing our Eli Lilly price target after another beat-and-raise quarter

The strength of its GLP-1 business suggests the stock still has more room to run.

from US Top News and Analysis https://ift.tt/cOZPKhM
https://ift.tt/Ry1FZwN

Comments

Popular posts from this blog